Search results
Predilation in pPCI
Added:
6 months ago
Article
Added:
9 months ago
Added:
1 week ago
Source:
Radcliffe Cardiology
The optimal timing for treating nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease remains a key clinical question. The iMODERN trial investigated whether an immediate intervention strategy was superior to a deferred approach in this patient population.¹The international, investigator-initiated, open-label iMODERN (Immediate or Deferred…
View more
Added:
2 weeks ago
Source:
Transcatheter Academy
The optimal timing for administering unfractionated heparin (UFH) to patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) has been a topic of discussion. The HELP-PCI trial investigated whether pre-treatment with UFH at first medical contact (FMC) improves outcomes compared to administration in the catheterisation laboratory (Cath…
View more
Added:
1 year ago
Added:
1 week ago
TCT 2025 - 10-year findings from NOBLE showed no safety concerns for percutaneous coronary intervention (PCI) compared to coronary artery bypass surgery (CABG) for the treatment of left main coronary artery (LMCA) disease.Dr Evald Høj Christiansen (Aarhus University Hospital, Aarhus, DK) joins us to share the 10-year mortality findings from the NOBLE trial, investigating PCI vs CABG in LMCA…
View more
Added:
2 months ago
Added:
1 year ago
Added:
1 year ago
Wire-based Techniques in CTO-PCI
Added:
12 months ago
Article